Evidence map›Paper›PMID 33764883›Full record

ArticleJournal of medical Internet research2021

Prediction and Feature Importance Analysis for Severity of COVID-19 in South Korea Using Artificial Intelligence: Model Development and Validation.

Heewon Chung, Hoon Ko, Wu Seong Kang, Kyung Won Kim, Hooseok Lee, Chul Park, Hyun-Ok Song, Tae-Young Choi, Jae Ho Seo, Jinseok Lee

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Heewon Chung *Department of Artificial Intelligence, The Catholic University of Korea, Bucheon, Republic of Korea.ORCID 0000-0002-4039-1419
Hoon Ko *Department of Artificial Intelligence, The Catholic University of Korea, Bucheon, Republic of Korea.ORCID 0000-0001-7807-215X
Wu Seong Kang *Department of Trauma Surgery, Jeju Regional Trauma Center, Cheju Halla General Hospital, Jeju, Republic of Korea.ORCID 0000-0003-0136-4458
Kyung Won KimRadiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-1532-5970
Hooseok LeeDepartment of Artificial Intelligence, The Catholic University of Korea, Bucheon, Republic of Korea.ORCID 0000-0003-1410-425X
Chul ParkDepartment of Internal Medicine, Wonkwang University School of Medicine, Iksan, Republic of Korea.ORCID 0000-0002-6031-009X
Hyun-Ok SongDepartment of Infection Biology, Wonkwang University School of Medicine, Iksan, Republic of Korea.ORCID 0000-0001-7953-3384
Tae-Young ChoiDepartment of Pathology, Wonkwang University School of Medicine, Iksan, Republic of Korea.ORCID 0000-0002-3285-0005
Jae Ho SeoDepartment of Biochemistry, Wonkwang University School of Medicine, Iksan, Republic of Korea.ORCID 0000-0002-8466-7800
Jinseok LeeDepartment of Artificial Intelligence, The Catholic University of Korea, Bucheon, Republic of Korea.ORCID 0000-0002-8580-490X
Catholic University of Korea · KRWonkwang University · KRCheju Halla General Hospital · KRUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of deaths from COVID-19 continues to surge worldwide. In particular, if a patient's condition is sufficiently severe to require invasive ventilation, it is more likely to lead to death than to recovery.

objectiveThe goal of our study was to analyze the factors related to COVID-19 severity in patients and to develop an artificial intelligence (AI) model to predict the severity of COVID-19 at an early stage.

methodsWe developed an AI model that predicts severity based on data from 5601 COVID-19 patients from all national and regional hospitals across South Korea as of April 2020. The clinical severity of COVID-19 was divided into two categories: low and high severity. The condition of patients in the low-severity group corresponded to no limit of activity, oxygen support with nasal prong or facial mask, and noninvasive ventilation. The condition of patients in the high-severity group corresponded to invasive ventilation, multi-organ failure with extracorporeal membrane oxygenation required, and death. For the AI model input, we used 37 variables from the medical records, including basic patient information, a physical index, initial examination findings, clinical findings, comorbid diseases, and general blood test results at an early stage. Feature importance analysis was performed with AdaBoost, random forest, and eXtreme Gradient Boosting (XGBoost); the AI model for predicting COVID-19 severity among patients was developed with a 5-layer deep neural network (DNN) with the 20 most important features, which were selected based on ranked feature importance analysis of 37 features from the comprehensive data set. The selection procedure was performed using sensitivity, specificity, accuracy, balanced accuracy, and area under the curve (AUC).

resultsWe found that age was the most important factor for predicting disease severity, followed by lymphocyte level, platelet count, and shortness of breath or dyspnea. Our proposed 5-layer DNN with the 20 most important features provided high sensitivity (90.2%), specificity (90.4%), accuracy (90.4%), balanced accuracy (90.3%), and AUC (0.96).

conclusionsOur proposed AI model with the selected features was able to predict the severity of COVID-19 accurately. We also made a web application so that anyone can access the model. We believe that sharing the AI model with the public will be helpful in validating and improving its performance.

Indexed as

Artificial IntelligenceAdolescentAdultAgedAged, 80 and overChildChild, PreschoolCOVID-19FemaleHumansInfantInfant, NewbornMaleMiddle AgedModels, StatisticalMortalityartificial intelligenceblood samplesCOVID-19mortality prediction

Identifiers

PMID33764883
PMCPMC8057199
OpenAlexW3137135253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.